Patient Care

  • WVU Cancer Institute debuts treatment for liver metastases

    WVU Cancer Institute debuts treatment for liver metastases

    A team of surgical oncologists from the WVU Cancer Institute, including Wallis Marsh, MD, Carl Schmidt, MD, and Brian Boone, MD, have performed the state’s first isolated hepatic perfusion, an operation that delivers chemotherapy directly to the liver to treat metastases that cannot be surgically removed.

    Read More

  • Lori Hazlehurst named as WVU Cancer Institute Associate Director

    Lori Hazlehurst named as WVU Cancer Institute Associate Director

    MORGANTOWN, W.Va. – Lori Hazlehurst, Ph.D., Professor (WVU School of Pharmacy - Pharmaceutical Sciences and Co-Leader of the WVU Cancer Institute Research Program the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, has been named as the Associate Director for Basic Research at the WVU Cancer Institute.  In this role, she will work closely with Dr. Richard Goldberg, Institute Director, and the leadership team of the WVU Cancer Institute to implement strategic goals to increase the impact of basic and translational cancer research at WVU. The primary strategy is to increase the number of NIH funded investigators focused on cancer research at WVU

    Read More

  • 2018 Cancer Burden Report Released

    WVU Cancer Institute's Cancer Prevention and Control, in collaboration with the West Virginia Cancer Registry, has released the 2018 Cancer Burden Report. The report provides updated statewide, age-adjusted incidence rates and counts for cancer diagnosed among West Virginia residents from 2011 to 2015.

    Read More